Glaucoma Awareness: Safeguarding Your Vision for a Lifetime
Glaucoma is one of the leading causes of irreversible blindness worldwide, but with early detection and proper management, vision loss can often be slowed or even prevented. As eye care continues to evolve, so does our understanding of this complex group of diseases, making ongoing education more important than ever.
What Is Glaucoma?
Glaucoma refers to a group of eye conditions that damage the optic nerve, typically due to increased intraocular pressure (IOP). The optic nerve is essential for transmitting visual information from the eye to the brain, and once damaged, vision loss cannot be reversed.
There are several types of glaucoma, but the two most common are:
Open-angle glaucoma – the most prevalent form, often developing slowly and without noticeable symptoms
Angle-closure glaucoma – less common but more acute, requiring immediate medical attention
Why Early Detection Matters?
One of the biggest challenges with glaucoma is that it is often called the “silent thief of sight.” In its early stages, there are usually no symptoms. By the time noticeable vision loss occurs, significant and permanent damage may already be done.
Routine eye exams are critical for early detection. These exams may include:
Measurement of intraocular pressure
Evaluation of the optic nerve
Visual field testing
Imaging of retinal nerve fiber layers
Beyond Eye Pressure: A Broader Understanding
While elevated IOP is a major risk factor, glaucoma is far more complex than just pressure alone. Modern research shows that:
Vascular health plays a role in optic nerve damage
Systemic conditions such as hypertension or diabetes may influence progression
Individual patient variability affects how glaucoma develops and responds to treatment
This means clinicians must take a holistic, patient-centered approach to care - combining diagnostics, lifestyle considerations, and tailored treatment plans.
Treatment Options: More Than Just Drops
Glaucoma management has advanced significantly in recent years. Today’s treatment options include:
Topical medications (eye drops) to lower IOP
Laser therapies such as SLT (Selective Laser Trabeculoplasty)
Minimally invasive glaucoma surgery (MIGS)
Traditional surgical procedures for advanced cases
Choosing the right treatment depends on the type of glaucoma, disease severity, and the patient’s overall health and lifestyle.
The Role of Comorbidities in Glaucoma Care
In real-world practice, glaucoma rarely exists in isolation. Many patients present with coexisting ophthalmic conditions such as dry eye disease, cataracts, macular degeneration, or diabetic retinopathy. These comorbidities can complicate both diagnosis and treatment.
For example:
Ocular surface disease may impact tolerance and adherence to topical therapies
Cataracts can influence visual field interpretation and surgical planning
Retinal conditions may mask or mimic glaucomatous changes
Managing these overlapping conditions requires:
Accurate and timely diagnosis
Tailored treatment strategies that consider the full ocular picture
Multidisciplinary coordination when systemic or retinal issues are involved
Efficiency in care delivery to reduce patient burden and appointment fatigue
A thoughtful, case-based approach helps clinicians balance disease control with patient quality of life, an increasingly important factor in long-term outcomes.
The Role of Continuing Education
As new technologies and treatment strategies emerge, eye care professionals must stay current to provide the best possible care. Understanding when to escalate treatment, how to interpret diagnostic data, and how to manage complex cases is essential in improving patient outcomes.
Join our upcoming 6-part series: Outsmarting the silent thief.
Part 1
Course Title: Advanced Glaucoma Diagnostics: From Classic Testing to Emerging Technology
Presenter: Dr. Nate Lighthizer
Date: Wednesday, August 12, 2026
This interactive lecture explores both classic and emerging diagnostic tools used in glaucoma care. Review essential testing including IOP measurement, visual fields, gonioscopy, and ONH imaging while gaining updates on OCT, OCT-A, color vision testing, and ERG. Learn how evolving technology supports earlier diagnosis, more precise management, and improved patient outcomes.
Part 2
Course Title: The Interventional Mindset: Managing Glaucoma in 2026
Presenter: Dr. Nora Cothran
Date: Wednesday, August 26th, 2026
This course encourages eye care professionals to cultivate an interventional mindset with regard to glaucoma diagnosis and management. Using a long-distance road trip as the analogy for a patient’s glaucoma journey, the instructors will provide evidence-based guidance and offer patient-centric strategies that maximize care. Paradigm-shifting studies and common MIGS will be reviewed. Grab your mix tape and snacks, and come along for the ride!
Part 3
Course Title: Visual Fields: What’s Old, What’s New, What’s Out, What’s In
Presenter: Dr. Danica Marrelli
Date: Wednesday, September 9th, 2026
This course reviews the basics of visual fields in glaucoma, providing a systematic approach to interpreting the printout. Emerging concepts such as the use of 10-2 visual field testing in early glaucoma, as well as new test patterns to emphasize early central loss are presented. A short discussion about headset (“virtual reality”) perimetry concludes the course.
Part 4
Course Title: Update on Topical Glaucoma Medications
Presenter: Dr. Phillip Yuhas
Date: Wednesday, September 23rd, 2026
This course provides an update on newly approved topical medications for the treatment of glaucoma and ocular hypertension. Emphasis is placed on each drug’s indications, contraindications, adverse effects, efficacy, and cost.
Part 5
Course Title: IOP Fluctuations & Home Monitoring – Future for Better Care
Presenter: Dr. Barbara Wirostko
Date: Thursday, October 8th, 2026
Attendees will gain a deep understanding of the role of intraocular pressure fluctuations and corneal hysteresis in glaucoma progression and their impact on treatment decisions. Through case studies and evidence-based discussions, participants will examine limitations of current monitoring methods and explore innovative technologies to support early detection and personalized glaucoma management.
Part 6
Course Title: The co-management of Glaucoma Surgery
Presenter: Dr. Elizabeth Muckley
Date: Wednesday, October 21st, 2026
This course reviews all FDA-approved surgical procedures for the treatment and management of glaucoma. Lasers, microinvasive techniques, and filtering surgeries are thoroughly covered, along with medical and pharmacologic postoperative management.